Scintigrafia con leucociti marcati nella diagnosi di infezione periprotesica di ginocchio: ha ancora senso farne uso?

Title

Code

SCIPROGIN

Type

Osservazionale

Start Year

2023

Status

Terminato

Principal Investigator

051-6366111 (centralino)

stefano.zaffagnini@unibo.it

Zaffagnini Stefano, MD

Director

2nd Orthopaedic and Traumatologic Clinic

Operational unit that carry out the study

complex unit

Clinica Ortopedica e Traumatologica II

Director

Zaffagnini Stefano, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. SCIPROGIN

Monday 5 June 2023, 14:41

PG0008702_2023_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

Scintigrafia con leucociti marcati nella diagnosi di infezione periprotesica di ginocchio: ha ancora senso farne uso?

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in